Concepedia

Melissa Alsina

MA

153

Publications

16.1K

Citations

62

H-Index

1994

Active since

Affiliations

Moffitt Cancer Center(Current)

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Hackensack University Medical Center

Emory University

Melissa Alsina is an author at Moffitt Cancer Center specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

1994–2025

153

Publications

153

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

Sundar Jagannath, Bart Barlogie, James R. Berenson et al. · British Journal of Haematology · 2004 · 739 citations · Full text

A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

David S. Siegel, Thomas G. Martin, Michael Wang et al. · Blood · 2012 · 654 citations · Full text

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Paul G. Richardson, Hannah Briemberg, Sundar Jagannath et al. · Journal of Clinical Oncology · 2006 · 644 citations · Full text

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

Paul G. Richardson, Emily Blood, Constantine S. Mitsiades et al. · Blood · 2006 · 520 citations · Full text

Rows per page

1–5 of 153